» Articles » PMID: 31878909

Comparative Assessment of Sarcopenia Using the JSH, AWGS, and EWGSOP2 Criteria and the Relationship Between Sarcopenia, Osteoporosis, and Osteosarcopenia in Patients with Liver Cirrhosis

Overview
Publisher Biomed Central
Specialties Orthopedics
Physiology
Date 2019 Dec 28
PMID 31878909
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Sarcopenia and osteoporosis reduce life quality and worsen prognosis in patients with liver cirrhosis (LC). When these two complications coexist, a diagnosis of osteosarcopenia is made. We aimed to investigate the actual situations of sarcopenia, osteoporosis, osteosarcopenia, and vertebral fracture, and to clarify the relationship among these events in patients with LC.

Methods: We describe a cross-sectional study of 142 patients with LC. Sarcopenia was defined according to the Japan Society of Hepatology (JSH) criteria, Asian Working Group for Sarcopenia (AWGS) criteria, and European Working Group on Sarcopenia in Older People (EWGSOP2) criteria. The skeletal muscle mass index (SMI) and handgrip strength were assessed using bioelectrical impedance analysis and a digital grip strength dynamometer, respectively. Bone mineral density (BMD) was measured using dual energy X-ray absorptiometry, and vertebral fracture was evaluated using spinal lateral X-rays. The severity of LC was assessed using the Child-Pugh classification.

Results: Among the 142 patients, the prevalence of sarcopenia was 33.8% (48/142) according to the JSH and AWGS criteria and 28.2% (40/142) according to the EWGSOP2 criteria. The number of patients with osteoporosis, osteosarcopenia, and vertebral fracture was 49 (34.5%), 31 (21.8%), and 41 (28.9%), respectively. Multivariate analysis revealed a close association between sarcopenia and osteoporosis. Osteoporosis was independently associated with sarcopenia [odds ratio (OR) = 3.923, P = 0.010]. Conversely, sarcopenia was independently associated with osteoporosis (OR = 5.722, P < 0.001). Vertebral fracture occurred most frequently in patients with osteosarcopenia (19/31; 61.3%) and least frequently in those without both sarcopenia and osteoporosis (12/76; 15.8%). The SMI and handgrip strength values were significantly correlated with the BMD of the lumbar spine (r = 0.55 and 0.51, respectively; P < 0.001 for both), femoral neck, (r = 0.67 and 0.62, respectively; P < 0.001 for both), and total hip (r = 0.67 and 0.61, respectively; P < 0.001 for both).

Conclusions: Sarcopenia, osteoporosis, osteosarcopenia, and vertebral fracture were highly prevalent and closely associated with one another in patients with LC. Specifically, patients with osteosarcopenia had the highest risk of vertebral fractures. Early diagnosis of these complications is essential for treatment intervention.

Citing Articles

Relationship between Sarcopenia and minimal hepatic encephalopathy in patients with cirrhosis: a prospective observational study.

Wongtrakul W, Bandidniyamanon W, Charatcharoenwitthaya P BMC Gastroenterol. 2025; 25(1):88.

PMID: 39962372 PMC: 11834310. DOI: 10.1186/s12876-025-03674-9.


Impact of frailty and prevalent fractures on the long-term prognosis of patients with cirrhosis: a retrospective study.

Niwa T, Saeki C, Saito M, Oikawa T, Kamioka H, Kanai T Sci Rep. 2025; 15(1):186.

PMID: 39747234 PMC: 11696115. DOI: 10.1038/s41598-024-83984-2.


Low geriatric nutritional risk index is associated with osteoporosis and fracture risk in patients with chronic liver disease: a cross-sectional study.

Kamioka H, Saeki C, Oikawa T, Kinoshita A, Kanai T, Ueda K BMC Gastroenterol. 2024; 24(1):376.

PMID: 39448932 PMC: 11515523. DOI: 10.1186/s12876-024-03465-8.


A short history of sarcopenia and frailty and their impact on advanced chronic liver disease.

Cuciureanu D, Filip P, Pop C, Diaconu S J Med Life. 2024; 17(7):660-664.

PMID: 39440333 PMC: 11493170. DOI: 10.25122/jml-2024-0304.


Quantitative Assessment of Body Composition in Cirrhosis.

Eriksen C, Moller S Diagnostics (Basel). 2024; 14(19).

PMID: 39410594 PMC: 11482591. DOI: 10.3390/diagnostics14192191.


References
1.
Nishikawa H, Shiraki M, Hiramatsu A, Moriya K, Hino K, Nishiguchi S . Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria. Hepatol Res. 2016; 46(10):951-63. DOI: 10.1111/hepr.12774. View

2.
Moriwaki H, Miwa Y, Tajika M, Kato M, Fukushima H, Shiraki M . Branched-chain amino acids as a protein- and energy-source in liver cirrhosis. Biochem Biophys Res Commun. 2003; 313(2):405-9. DOI: 10.1016/j.bbrc.2003.07.016. View

3.
Collier J . Bone disorders in chronic liver disease. Hepatology. 2007; 46(4):1271-8. DOI: 10.1002/hep.21852. View

4.
Hayashi M, Abe K, Fujita M, Okai K, Takahashi A, Ohira H . Association between sarcopenia and osteoporosis in chronic liver disease. Hepatol Res. 2018; 48(11):893-904. DOI: 10.1111/hepr.13192. View

5.
Buckinx F, Landi F, Cesari M, Fielding R, Visser M, Engelke K . Pitfalls in the measurement of muscle mass: a need for a reference standard. J Cachexia Sarcopenia Muscle. 2018; 9(2):269-278. PMC: 5879987. DOI: 10.1002/jcsm.12268. View